Even though anti-inflammatory effects are important to prevent liver fibrosis by inhibiting the activation of HSC, a recent study has revealed the unbeneficial potential of TGR5 to promote liver fibrosis. This evidence concerns the gene GPBAR1 and Hepatic fibrosis.